Multi-omics analysis reveals regulators of the response to PDGF-BB treatment in pulmonary artery smooth muscle cells
- PMID: 27716141
- PMCID: PMC5053085
- DOI: 10.1186/s12864-016-3122-3
Multi-omics analysis reveals regulators of the response to PDGF-BB treatment in pulmonary artery smooth muscle cells
Abstract
Background: Pulmonary arterial hypertension (PAH) is a lethal disease with pronounced narrowing of pulmonary vessels due to abnormal cell proliferation. The platelet-derived growth factor BB (PDGF-BB) is well known as a potent mitogen for smooth muscle cell proliferation. To better understand how this growth factor regulates pulmonary arterial smooth muscle cells (PASMCs) proliferation, we sought to characterize the response to PDGF-BB stimulation at system-wide levels, including the transcriptome and proteome.
Results: In this study, we identified 1611 mRNAs (transcriptome), 207 proteins (proteome) differentially expressed in response to PDGF-BB stimulation in PASMCs based on RNA-sequencing and isobaric tags for relative and absolute quantification (iTRAQ) assay. Transcription factor (TF)-target network analysis revealed that PDGF-BB regulated gene expression potentially via TFs including HIF1A, JUN, EST1, ETS1, SMAD1, FOS, SP1, STAT1, LEF1 and CEBPB. Among them, SMAD1-involved BMPR2/SMADs axis plays a significant role in PAH development. Interestingly, we observed that the expression of BMPR2 was decreased in both mRNA and protein level in response to PDGF-BB. Further study revealed that BMPR2 is the direct target of miR-376b that is up-regulated upon PDGF-BB treatment. Finally, EdU incorporation assay showed that miR-376b promoted proliferation of PASMCs.
Conclusion: This integrated analysis of PDGF-BB-regulated transcriptome and proteome was performed for the first time in normal PASMCs, which revealed a crosstalk between PDGF signaling and BMPR2/SMADs axis. Further study demonstrated that PDGF-BB-induced miR-376b upregulation mediated the downregulation of BMPR2, which led to expression change of its downstream targets and promoted proliferation of PASMCs.
Keywords: BMPR2; Platelet-derived growth factor-BB (PDGF-BB); Pulmonary arterial hypertension (PAH); RNA sequencing; iTRAQ; miR-376b.
Figures
Similar articles
-
Crucial role of RAGE in inappropriate increase of smooth muscle cells from patients with pulmonary arterial hypertension.PLoS One. 2018 Sep 4;13(9):e0203046. doi: 10.1371/journal.pone.0203046. eCollection 2018. PLoS One. 2018. PMID: 30180189 Free PMC article.
-
The Long Noncoding RNA LnRPT Is Regulated by PDGF-BB and Modulates the Proliferation of Pulmonary Artery Smooth Muscle Cells.Am J Respir Cell Mol Biol. 2018 Feb;58(2):181-193. doi: 10.1165/rcmb.2017-0111OC. Am J Respir Cell Mol Biol. 2018. PMID: 28915060
-
Inhibitory effect of NBL1 on PDGF-BB-induced human PASMC proliferation through blockade of PDGFβ-p38MAPK pathway.Biosci Rep. 2016 Aug 31;36(4):e00374. doi: 10.1042/BSR20160199. Print 2016 Aug. Biosci Rep. 2016. PMID: 27474499 Free PMC article.
-
Role of platelet-derived growth factor-BB (PDGF-BB) in human pulmonary artery smooth muscle cell proliferation.J Recept Signal Transduct Res. 2014 Aug;34(4):254-60. doi: 10.3109/10799893.2014.908915. Epub 2014 May 7. J Recept Signal Transduct Res. 2014. PMID: 24804810
-
[Effect of yifei huoxue granule on the proliferation and the TGF-beta activity of rat pulmonary artery smooth muscle cells induced by platelet-derived growth factor BB].Zhongguo Zhong Xi Yi Jie He Za Zhi. 2011 Sep;31(9):1239-42. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2011. PMID: 22013804 Chinese.
Cited by
-
BMPR2 mutation and clinical response to imatinib in a case of heritable pulmonary arterial hypertension.Pulm Circ. 2024 Jan 10;14(1):e12335. doi: 10.1002/pul2.12335. eCollection 2024 Jan. Pulm Circ. 2024. PMID: 38213946 Free PMC article.
-
Pharmacology and Rationale for Seralutinib in the Treatment of Pulmonary Arterial Hypertension.Int J Mol Sci. 2023 Aug 10;24(16):12653. doi: 10.3390/ijms241612653. Int J Mol Sci. 2023. PMID: 37628831 Free PMC article. Review.
-
Novel Molecular Mechanisms Involved in the Medical Treatment of Pulmonary Arterial Hypertension.Int J Mol Sci. 2023 Feb 19;24(4):4147. doi: 10.3390/ijms24044147. Int J Mol Sci. 2023. PMID: 36835558 Free PMC article. Review.
-
New trends in pulmonary hypertension.Eur Respir Rev. 2023 Feb 21;32(167):220211. doi: 10.1183/16000617.0211-2022. Print 2023 Mar 31. Eur Respir Rev. 2023. PMID: 36813291 Free PMC article.
-
Purine synthesis suppression reduces the development and progression of pulmonary hypertension in rodent models.Eur Heart J. 2023 Apr 7;44(14):1265-1279. doi: 10.1093/eurheartj/ehad044. Eur Heart J. 2023. PMID: 36721994 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous